Go to main website
Sensus Healthcare - Logo

Press Releases

Sensus Healthcare Reports Third Quarter 2020 Financial Results

Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 05, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and nine months ended September 30, 2020. Highlights from the […]
READ MORE

Sensus Healthcare Appoints Megan Cornish to its Board of Directors

Gains valuable Capitol Hill, business strategy and marketing experience BOCA RATON, Fla, Nov. 05, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the appointment of Megan Cornish to its board of directors, effective January 1, 2021. Ms. […]
READ MORE

Sensus Healthcare to Host Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020

BOCA RATON, Fla. , Oct. 29, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 5, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the third […]
READ MORE

Sensus Healthcare Announces Publication of Study Showing Use of Superficial Radiation Therapy Post-Keloidectomy Prevents Keloid Recurrence

Keloid recurrence rate of 10.4% at 12 months for patients treated with SRT following keloidectomy compares with more than 80% with surgical excision alone Retrospective study published in Journal of Clinical and Aesthetic Dermatology BOCA RATON, Fla., Oct. 22, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, […]
READ MORE

Sensus Healthcare Reports Second Quarter 2020 Financial Results

Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 06, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and six months ended June 30, 2020. Highlights from the […]
READ MORE

American Society of Radiologic Technologists Approves Sensus Healthcare's SRT Systems for Continuing Education Units

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems BOCA RATON, Fla, Aug. 05, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, and the leading provider of superficial radiotherapy […]
READ MORE

Get notified about Sensus Healthcare

Get Email Alerts
Sensus Healthcare - Logo - Footer
Sensus Healthcare partners with The Pinnacle Health Group to provide reimbursement support for all customers. Please contact Pinnacle for support by phone at 866-369-9290 or email at [email protected]. Hotline consultants are available Monday through Friday from 8:30 AM to 6:00 PM EST.
Contact Us
Sensus Healthcare World Headquarters:

851 Broken Sound Parkway
Boca Raton, FL 33487
[email protected]

Phone 561.922.5808
Toll-free 800.324.9890
Fax 561.948.2071
© Copyright 2023. Sensus Healthcare - All Rights Reserved.